Unsorted B/I activated lymphocytes, CD62L+ cells that remained CD62L+ after B/I and expansion (CD62L+ → CD62L+ ), CD62L+ cells that downregulated CD62L after B/I treatment and expansion (CD62L+ → CD62L- ), CD62L- cells that remained CD62L- after B/I treatment and expansion (CD62L- →CD62L- ), or CD62L- cells that upregulated CD62L expression after B/I and expansion (CD62L- → CD62L+ ) were infused into CYP pre-treated tumor bearing mice (Figure 5). Here, SELL is linked to neoplasm.